
James F. McDonough
Of Counsel
732-568-8360 jmcdonough@sh-law.comFirm Insights
Author: James F. McDonough
Date: January 28, 2015

Of Counsel
732-568-8360 jmcdonough@sh-law.comOn Jan. 7, a bipartisan group of lawmakers forecast the U.S. House of Representatives would finally succeed in its efforts to repeal the medical device tax component of Obamacare, after pushing this agenda for years.
The latest legislation floated to repeal this provision, a bill that Rep. Erik Paulsen, R-Minn. introduced Jan. 6, has managed to secure the support of most of the House’s members, including Democrats, according to The Hill. This momentum has built up after Republicans contended for months that if they managed to win control of the legislature, eliminating this tax would be one of their primary objectives.
“Many of us were saying from the outset this is a very ill-conceived idea,” Paulsen stated during a news conference Jan. 7, the media outlet reported. “You’re going to have fewer start-ups, less ideas in the garage.”
The congressman, who just began his fourth term in Congress, has repeatedly proposed bills that would eliminate this provision, Washington Correspondent Brett Neely recently wrote in MPR News. While his legislation obtained the House’s approval twice since 2012, the initiative tasted defeat upon reaching the Senate.
However, the situation may prove different this time, as the bill failed to pass the Senate when the legislative body was controlled by Democrats, Neely emphasized. His latest bill commands the support of 257 members of the House, and the Democrats who support the initiative have indicated they are behind the measure because they want to benefit medical device companies in their districts.
“Repealing this tax has strong bipartisan support across the political spectrum,” he said at the conference Jan. 7, the author wrote. “We’ve been in the red zone before but now with new Senate leadership, we’re confident we can get it across the goal line.”
While Paulsen may be optimistic about the effort’s prospects, supporting lawmakers could run into trouble if they are unable to find methods of offsetting the revenue lost by eliminating the tax, according to The Hill. The provision currently generates close to $30 billion over the course of 10 years.
However, Paulsen has indicated he isn’t worried about that hurdle, and both he and Rep. Ron Kind, D-Wis. have predicted that members of the House and Senate – Democrat and Republican alike – will find a way to cover the lost revenue, the media outlet reported. Paulsen emphasized that the House has done that before, approving legislation in 2012 that would have recovered subsidy overpayments from Obamacare and used that to pay for the income shortfall.
In the event that the legislature can come to an agreement, a final hurdle remains. Currently, it is unclear whether Pres. Barack Obama would veto the proposal should it come to his desk. Obama has previously threatened to veto the medical device tax repeal, The Hill noted.
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.

IP infringement occurs when someone uses your intellectual property without your permission or beyond the scope of the permission you granted. Common examples of IP infringement include copying a product’s patented features or using a trademarked logo in a way that is likely to confuse consumers about the source or affiliation of goods or services. […]
Author: Michael Mietlicki

When facing public allegations of wrongdoing, companies should not let the speed of the public conversation dictate the speed of an investigation. An investigation designed to confirm a preferred narrative rather than establish the facts can create serious problems later, particularly if litigation, regulatory scrutiny, or employment claims follow. Key Takeaways When public allegations surface […]
Author: Sean M. Pena

For battery energy storage system (BESS) developers, securing equipment and site control is only part of the development equation. A project must also connect to the electric grid, and increasingly, BESS interconnection is one of the biggest sources of schedule, cost, and contractual risk. Key Takeaways This article is Part 3 of our Battery Storage […]
Author: Nicholas Wall

Director and officer liability increases sharply when a company is in financial distress. Decisions that would draw little attention in a healthy business can later be challenged by creditors, shareholders, bankruptcy trustees, and regulators as breaches of fiduciary duty, fraudulent transfers, or oversight failures. Understanding where that exposure comes from, and how to manage it, […]
Author: Michael Mietlicki

For developers pursuing battery energy storage system (BESS) projects, finding the right property is only the beginning. BESS site selection is as much a legal and transactional exercise as a real estate decision, with risk analysis central to the project’s ultimate success. Key Takeaways The core questions for BESS site selection in New York and […]
Author: Nicholas Wall

What should you expect when meeting a litigation attorney about a business dispute? You should expect to describe the dispute in your own words, hand over the most important documents, flag any deadlines or immediate threats, and leave with a clearer picture of the problem, what information is still needed, and the likely next steps. […]
Author: Michael Mietlicki
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.
Let`s get in touch!
Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!